symmetric dimethylarginine has been researched along with 2019 Novel Coronavirus Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Doğan, Ö; Haşimi, A; Serdar, CC; Serdar, MA | 1 |
| Balfanz, P; Böger, R; Dahl, E; Dreher, M; Hannemann, J; Hartmann, B; Marx, N; Müller-Wieland, D; Schwedhelm, E; Ule, J | 1 |
2 other study(ies) available for symmetric dimethylarginine and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
Association of serum ADMA, SDMA and L-NMMA concentrations with disease progression in COVID-19 patients.
Topics: Arginine; COVID-19; Disease Progression; Humans; omega-N-Methylarginine | 2023 |
Elevated serum SDMA and ADMA at hospital admission predict in-hospital mortality of COVID-19 patients.
Topics: Aged; Aged, 80 and over; Arginine; Biomarkers; Cohort Studies; COVID-19; Female; Hospital Mortality; Hospitalization; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Risk Factors; SARS-CoV-2 | 2021 |